Lagis Enterprise Co., Ltd. (6730.TWO)

TWD 36.7

(0.0%)

EBITDA Summary of Lagis Enterprise Co., Ltd.

  • Lagis Enterprise Co., Ltd.'s latest annual EBITDA in 2023 was 112.36 Million TWD , down -6.91% from previous year.
  • Lagis Enterprise Co., Ltd.'s latest quarterly EBITDA in 2024 Q1 was 29.37 Million TWD , down -2.54% from previous quarter.
  • Lagis Enterprise Co., Ltd. reported an annual EBITDA of 120.57 Million TWD in 2022, up 30.77% from previous year.
  • Lagis Enterprise Co., Ltd. reported an annual EBITDA of 92.3 Million TWD in 2021, up 36.23% from previous year.
  • Lagis Enterprise Co., Ltd. reported a quarterly EBITDA of 29.37 Million TWD for 2024 Q1, down -2.54% from previous quarter.
  • Lagis Enterprise Co., Ltd. reported a quarterly EBITDA of 27.65 Million TWD for 2023 Q3, up 24.75% from previous quarter.

Annual EBITDA Chart of Lagis Enterprise Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Lagis Enterprise Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 112.36 Million TWD -6.91%
2022 120.57 Million TWD 30.77%
2021 92.3 Million TWD 36.23%
2020 67.82 Million TWD -50.37%
2019 136.51 Million TWD 0.0%

Peer EBITDA Comparison of Lagis Enterprise Co., Ltd.

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 88.886%
Bioteque Corporation 736.13 Million TWD 84.736%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD 4.413%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -46.664%
BenQ Medical Technology Corporation 532.15 Million TWD 78.885%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 83.324%
Unicon Optical Co., Ltd. 377.24 Million TWD 70.215%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 89.252%
Medeon Biodesign, Inc. -1.14 Billion TWD 109.84%
Concord Medical Co., Ltd. 137.47 Million TWD 18.265%
Crystalvue Medical Corporation 149.73 Million TWD 24.956%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD 2.698%
ICARES Medicus, Inc. 165.54 Million TWD 32.123%
Amed Co., Ltd. 157.32 Million TWD 28.579%